Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Oasmia Has Submitted a Marketing Authorization Application to the European Medicines Agency for Its Lead Cancer Product Apealea(R) (Paclical(R)) 2016-02-08 20:23
1